We proposed to retain these deleted bypass codes on the proposed CY 2026 bypass list because these codes existed in CY 2024 and were covered HOPD services in that period, and CY 2024 claims data were used to calculate proposed CY 2026 payment rates
8 Conclusions L-asparaginase (L-ASNase) is at the center and complex enzyme in the field of cancer treatment and especially in the specific therapeutic control of acute lymphoblastic leukemia (ALL)
By blocking NNMT activity, it increases critical cellular metabolites (SAM, NAD) that drive downstream increases in energy expenditure and metabolic health 1-4
These characteristics, combined with its demonstrated bioactivity across diverse tissue types, suggest it may serve as a model compound for further pharmacological exploration
Choose your group Select your qualifying category above Verify with GovX ID Secure, private verification no documents shared with Peppy&Me Receive your discount A unique 15% code is emailed to you instantly Get the latest research, first
